Comparative analysis of the mammalian WNT4 promoter
© Yu et al; licensee BioMed Central Ltd. 2009
Received: 19 December 2008
Accepted: 6 September 2009
Published: 6 September 2009
WNT4 is a critical signalling molecule in embryogenesis and homeostasis, but the elements that control its transcriptional regulation are largely unknown. This study uses comparative cross species sequence and functional analyses between humans and a marsupial (the tammar wallaby,Macropus eugenii) to refine the mammalian Wnt4 promoter.
We have defined a highly conserved 89 bp minimal promoter region in human WNT4 by comparative analysis with the tammar wallaby. There are many conserved transcription factor binding sites in the proximal promoter region, including SP1, MyoD, NFκB and AP2, as well as highly conserved CpG islands within the human, mouse and marsupial promoters, suggesting that DNA methylation may play an important role in WNT4 transcriptional regulation.
Using a marsupial model, we have been able to provide new information on the transcriptional regulators in the promoter of this essential mammalian developmental gene, WNT4. These transcription factor binding sites and CpG islands are highly conserved in two disparate mammals, and are likely key controlling elements in the regulation of this essential developmental gene.
Wingless-type MMTV integration site family, member 4 (WNT4) is a locally acting signalling molecule, regulating cell-cell interactions, proliferation, differentiation, migration, and gene activation [1–10]. It is a highly conserved gene within mammals and has multiple roles in organogenesis and homeostasis and is of special interest in the sexual differentiation of the ovary [11–24]. While it can elicit its effects through the "canonical" WNT/β-catenin signalling pathway , it mainly acts through "non-canonical" signalling pathways. The WNT4 signalling pathway is mediated by the factor c-Jun N-terminal Kinase (JNK) in both the frog eye and human kidney development [16, 25, 26]. While WNT4 function is well defined, the underlying mechanisms that regulate its expression are still largely unknown.
Marsupials are mammals that diverged from the eutherian mammal lineage around 130 million years ago. Marsupials differ from other mammals in subtle ways especially in their mode of reproduction . We use the tammar wallaby as the model marsupial because most sexual differentiation occurs after birth, unlike in eutherian mammals where differentiation of the testis and ovary occurs in utero [28, 29]. We now know that WNT4 appears to be as important in differentiation of the marsupial ovary as it is in eutherians , suggesting that this gene has been highly conserved during therian (eutherian and marsupial) evolution. Despite its importance as a developmental regulator, the regulation of WNT4 has not been clearly defined. It is hard to distinguish functional from non-functional sequences in the promoter region by comparing closely related species such as mouse and human. It was therefore of interest to examine the promoter region of this important gene in representatives of the two therian mammal groups that diverged over 130 million years ago.
Initiation of transcription is the primary mechanism by which genes are regulated and is dependent on the structure of the promoter region and the corresponding transcription factor binding sites. There has been some analysis of the WNT4 promoter region. The human WNT4 immediate 5'-flanking region (1.2 kb) has promoter activity, but the critical promoter elements have not yet been defined . Although WT1 down-regulates WNT4 gene expression in vitro, no active WT1 binding sites have been identified in the 1.2 kb promoter region by reporter analysis . p21 is a negative transcriptional regulator of Wnt4 expression in keratinocyte growth control . Furthermore, P21 binding to the Wnt4 promoter is mediated through the transcriptional factor E2F-1 , and there is an E2F-1 binding site near the TATA box-proximal region of the mouse Wnt4 promoter . In gonadal development, fibroblast growth factor 9 (FGF9) and WNT4 appear to act as antagonistic signals to regulate mammalian sexual differentiation . In mouse kidney development, the transcriptional factor PAX2 activates Wnt4 expression in vitro and in vivo, and also directly activates human WNT4 promoter activity . Furthermore, there are three PAX2 recognition motifs in the 5'-flanking sequence of the human WNT4 gene  but the precise pathway of transcriptional regulation of WNT4 gene in renal development is still unclear. There is a novel response element (RRRCWWGYYY) in the human WNT4 promoter that confers p63- and p73-specific activation . Together, these studies contribute to our understanding of WNT4 transcriptional regulation mechanisms, but how transcriptional modulation and chromatin structure remodelling are controlled by the promoter is still poorly understood and as yet there is no complete analysis of the WNT4 promoter.
Comparative genomics is a powerful way to identify conserved elements of genes and promoter regions likely to be essential for their function . Selecting suitable species is the key for evolutionary comparisons. If closely related species are selected, it is very hard to distinguish the random sequences from the functional sequences. Marsupials provide an ideal model for the identification of conserved mammalian gene features since they diverged from mice and humans over 130 million years ago . Elements conserved between mice and humans (eutherian mammals) and the tammar wallaby (a marsupial mammal) over this long period of divergent evolution are therefore likely to be critical to their function.
This is the first study of the WNT4 promoter in any non-eutherian mammal. We used comparative genomics to isolate conserved mammalian promoter elements, and examined their function in promoter construct assays in both tammar primary cell lines as well as human cell lines. This has enabled identification of the conserved elements of the promoter and transcriptional factor binding sites (TFBS) likely to be essential in the regulation of WNT4. We have also analysed the human WNT4 promoter in these cell lines and compared their activities to further define the function of this region.
Cloning of tammar and human WNT4 5' flanking sequence
Primers designed for promoter analysis
with hRL, 1968 bp
with hRL, 1608 bp
with hRL, 895 bp
with hRL, 255 bp
p hWNT4 FD
with hRD, 1061 bp
p hWNT4 RD
with tRL, 2839 bp
with tRL, 1998 bp
with tRL, 994 bp
with tRL, 616 bp
with tRL, 315 bp
p tWNT4 FD
with tRD, 2168 bp
p tWNT4 RD
tWNT4 expression (102 bp)
hWNT4 expression (160 bp)
Comparative analysis of the WNT4 upstream and downstream genomic sequences
Identification of the conserved WNT4 promoter region
We did not identify a TATA box immediately 5' of the transcription start site and no CCAAT sequence was identified in the proximal promoter region. However, very high GC content and CpG islands are conserved features of this region (Figure 3).
Functional analysis of the Wnt4 promoter region
Maximum promoter activity was found in the tammar -530/+70 fragment within tammar kidney primary cell lines and human HEK293T kidney cell lines. Smaller constructs (-229/+70) showed very low promoter activity in the above two cell lines. Larger fragments (up to -2753), had reduced activity, indicative of transcriptional repressors present further 5' in the promoter region. Transcriptional inhibitor binding sites appeared to be present in the -2753/-908 regions of the tammar promoter because the transcriptional activity was lower in these longer regions in all three different cell lines and much lower than in the -530/+70 (kidney) and -980/+70 (lung) regions. However, in the tammar lung primary cell line, the -980/+70 showed the highest promoter activity, above that of the -530/+70 fragment from kidney. This suggests that important lung cell TFBS are likely to be located within this region (-530 to - 980) to increase gene function by protein-DNA or protein-protein interactions. Noticeably, we also found that the fragment -229/+70 has almost double the activity compared to "no insert" control in the tammar lung primary cell lines, suggesting the different cellular context is very important for activation of gene transcription. In addition, minimal promoter refers to the shortest fragment that can drive the gene initiation or expression. Taken together, these data suggest that the tammar WNT4 minimal promoter region lies in the -530/+70 region in vitro.
These findings are consistent with previous analyses, which suggest that the human WNT4 promoter is located in the -781/+102 fragment and larger fragments (up to -1854 bp) showed reduced promoter activity suggesting negative regulator binding sites within this region . Furthermore, the immediate 5' region (-141 bp) also had no promoter activity. Interestingly, we also found that human promoter constructs had higher relative expression in tammar cell lines than the corresponding tammar promoter constructs. This may be due to subtle differences in the regions covered by fragments derived from each species for analysis. However, while the activities of promoters were variable between species, both marsupial and human promoter regions show similar trends between comparable promoter regions.
Chromosome localization of WNT4 gene in known species
WNT4 is an essential gene in embryogenesis, critical for the development of kidney, adrenal, gonad, mammary gland and eye [10, 16, 22, 23, 39]. Despite its many functions, the transcriptional regulation of the WNT4 gene remains poorly characterised. In this comparative analysis of the mammalian WNT4 promoter, we have refined the promoter and identified evolutionarily conserved TFBS that appear to be important for WNT4 transcriptional regulation in kidney and lung, in all mammals including man. Since these regions have been conserved in sequence and function for over 130 million years , they are likely to represent promoter and enhancer regions critical for mammalian WNT4 gene regulation.
We found several conserved putative TFBS in both the human and tammar promoter regions. These were mainly conserved within an 89 bp transcription module, designated as TF module I, which shared a 97% identity between human and tammar (Figure 2). We also identified a conserved MyoD-SP1-MyoD transcription module between module I and the transcription start site (TSS), which could have a central role in transcriptional regulation. SP1 is one of the first eukaryotic transcription factors to stimulate or repress transcription by binding/competing to the GC/GT elements or recruiting chromatin remodelers [40, 41]. Except for the 4 common SP1 binding sites shared across species, the tammar has an additional 9 and human an additional 7 SP1 binding sites predicted between the TSS and TF module I (data not shown). SP1 therefore could have an essential role in initiation of WNT4 gene expression. We found a conserved binding site for the Zinc finger binding protein (ZBP), a transcriptional regulator involved in cell proliferation and differentiation [42, 43]. A conserved Nuclear Factor κB (NFκB) binding site was also found in TF module I. NFκB regulates target genes at several levels including controlled cytoplasmic-nuclear shuttling and modulation of transcriptional activity . We also identified PAX5 and PAX3 TFBS in the TF Module I. Interestingly, PAX2 has been shown to bind to the WNT4 promoter and activate its expression during the kidney development . However, this motif does not appear to be conserved in the tammar core promoter. The sequence about 0.45 kb upstream of the transcriptional start site in the human promoter had homology to both the consensus PAX2 motif proposed by Brophy et al.,  and to the PAX5 motif predicated by MatInspector software . There is some crossover between PAX2 and PAX5 when binding the mb-1 probe and recruitment of Est-1 . Taken together, this motif is highly conserved and may act as a PAX2 binding site depending on the cellular environment. MyoD, another identified transcription factor binding to this region, directly regulates gene expression by modulation of the chromatin structure in myogenesis . WNT4 is expressed in tammar and human muscle and involved in the control of smooth muscle cell fate [3, 13] but the factors that regulate its expression in this process are unknown. Our findings suggest that MyoD could play a conserved role in the regulation of WNT4 gene expression.
Both human and tammar proximal promoters lack the typical canonical TATA box and CCAAT box. Instead, they feature a high GC content and CpG islands, suggesting other mechanisms, such as DNA methylation and chromatin remodelling are required to initiate WNT4 transcription. High GC content and CpG islands are typical signatures of promoters that lack a TATA box and the usual initiation elements . DNA methylation can occur on the cytosine base of high GC content regions, and inhibit transcription through the binding of methyl-CpG-binding proteins or by blocking binding of specific transcriptional activators [49, 50]. Thus, DNA methylation and demethylation can act as an alternative mechanism to regulate gene activation. Most housekeeping genes are expressed constitutively where CpG islands are unmethylated, whereas the WNT4 gene is a spatially and temporally regulated gene during development. Our analysis suggests the regulation of WNT4 is mediated, at least in part, by DNA methylation. However, to confirm this method of WNT4 regulatory control, it would be essential to investigate the DNA methylation status of the GC rich region in different tissues. Interestingly, there is a TATA box in the mouse proximal promoter, inferring that the mouse may have developed an additional regulatory region. However, the mouse Wnt4 promoter still retains the proximal GC rich region as seen in humans and tammar wallaby.
We also identified a highly conserved region in intron 1 of the tammar, opossum, human and mouse, which could contain downstream regulatory or enhancer elements. However, when blasting these highly conserved sequences against EST databases in GenBank, we found that they are expressed in the fetal heart of humans from 19 weeks and also in the Wolffian ducts of embryonic day 12 mice. Thus, this region may represent a new gene which overlaps with WNT4 or a rare alternative transcript. Nevertheless, further investigations are needed to define its expression and function, and to determine its relationship, if any, to WNT4.
In order to compare the conserved promoter activity of the tammar and human WNT4 genes, we performed cross-transfection of promoter constructs in both human and tammar cell lines. This is the first functional analysis of a tammar wallaby gene promoter, confirming that primary cell lines can be useful for this type of analysis. The human constructs had a higher relative expression in tammar cell lines than the tammar constructs. One possible reason is that there are more TFBS in human constructs to activate gene expression or fewer inhibitors to repress gene expression. However, similar results were obtained for orthologous promoter regions in both species across both cell lines. This shows that the TFBS have maintained conserved functions over at least 130 million years, indicating they are likely to be critical for gene function. Our deletion analysis further refined which parts of the conserved region contain the functional promoter region of the WNT4 gene and the putative TFBS required for its activation. Although this study has identified numerous highly conserved TFBSs, further study, including ChIP/EMSA and mutation and transfection analysis is needed to define the precise role of each transcription factor in the regulation of the mammalian WNT4 gene.
This is the first comparative study of the mammalian WNT4 promoter. Using a marsupial model, we have been able to provide new information on the transcriptional regulators in the promoter of this essential mammalian developmental gene. These transcription factor binding sites and CpG islands are highly conserved in two disparate mammals, and are likely key controlling elements in the regulation of this essential developmental gene. These findings provide a platform for further targeted approaches to defining the precise function of each TFBS in WNT4 regulation.
Cloning the 5' Upstream Region of WNT4 Gene in Tammar and Human
The transcription start site was determined according to our previous analysis of tammar WNT4 gene . Briefly, we amplified tammar WNT4 partial sequence with degenerated primers, and then employed 5'RACE and 3'RACE to obtain the upstream and downstream sequences from this partial sequence. We just got one band with 5'RACE and multiple bands with 3'RACE, and confirmed these transcripts/isoforms with primers from 5'UTR and 3'UTR. The tammar BAC library was screened according to previous methods with the tammar 32P-labelled WNT4 partial sequence as a probe . BAC DNA was digested with EcoRI, and shotgun subcloned into the pBluescript II SK (-) vector. Primers within tammar exon 1 (E1F and E1R, Table 1), were used to screen the clones. An equivalent region was amplified (primers: phWNT4F and phWNT4R, Table 1) from the human genomic based on the human WNT4 genomic sequence http://www.ensembl.org/index.html.
In Silico Analysis of the mammalian WNT4 Regulatory Region
Human, mouse and opossum WNT4 genomic sequences including 3 kb upstream and downstream of the start codon were retrieved from the Ensembl website http://www.ensembl.org. Sequence alignments were performed using MULAN http://mulan.dcode.org/.
The potential TFBS of the minimal promoter region defined by deletion analysis were predicated by AliBaba2.1 http://www.gene-regulation.com/pub/programs/alibaba2/index.html and MULAN http://mulan.dcode.org/. Core-search to define the unknown motifs in the 5' flanking regions (2874 bp) of WNT4 gene in the tammar (GenBank: EU003446), mouse and human was carried out using GEMS, Genomatix software http://www.genomatix.de. CpG islands were predicated by cpgplot http://www.ebi.ac.uk/emboss/cpgplot/.
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Intron spanning primers were used to confirm endogenous WNT4 gene expression in the cell lines chosen for transfections. Tammar WNT4 was amplified with tWNT4F and tWNT4R (Table 1)  while human was amplified using hWNT4F and hWNT4R (Table 1). Total RNA was isolated from cells using the GeneElute kit (Sigma, Castle Hill, NSW, Australia), and the quality and quantity of total RNA verified with the NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, USA). 2 μg of total RNA was DNase-treated with DNA-free (Ambion Inc., Austin, Texas, USA). 1 μg of total RNA was reverse-transcribed using SuperScript III (Invitrogen, California, USA). PCR was performed in a 50 μl reaction containing 10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl2, 50 mM KCl, 200 μM dNTP, 0.2 μM each primer, 1 U Taq DNA polymerase (Promega, Wisconsin, USA). Amplification conditions were: 94°C, 30 s; 56°, 30 s, 72°C, 30 s for 38 cycles.
Generation of Luciferase Reporter Constructs
Primers were engineered with Acc65I and Xhol restricted enzyme sites to allow directional cloning of fragments into a luciferase expression vector (pGL4.10, Promega, USA). PCR was performed (primer sequences, Table 1) with GC-RICH PCR System (Roche, Germany) according to the manufacturer's protocol because of high GC content in the promoter region. The PCR products and vector were then digested with these two enzymes and ligated to screen the promoter-luc2 constructs. All PCR products and constructs were purified with Qiagen gel extraction and purification kits (Qiagen, Doncaster, VIC, Australia), and the concentration of constructs determined with a NanoDrop N-1000 spectrophotometer (NanoDrop Technologies, Wilmington, USA).
Cell Culture, Transient Transfection and Luciferase Assays
All cells were cultured at 37°C with 6% CO2 in a humidified incubator. Human embryonic kidney HEK293T cells were grown in Dulbecco's modified Eagle medium (DMEM) (GIBCO, Invitrogen) with 10% fetal bovine serum (FBS). Tammar lung primary cells (low passages) from Day 70 after birth removed pouch young (RPY) were grown in 50% DMEM containing 10% FBS and 50% AminoMax (GIBCO, Invitrogen) containing 15% fetal calf serum (FCS). Tammar kidney primary cells (low passages) from D30 after birth RPY were grown in 100% AminoMax with 15% FCS.
For transient transfection studies, cells were seeded into 24-well tissues culture plates for HEK293T or 12-well tissue plates for tammar primary cells at optimal densities. Approximately 24 hours after plating, HEK293T cells with 60-70% confluence or tammar primary cells with 80-90% confluence were transfected with human or tammar truncated promoter region fragment-luciferase reporter gene constructs and basal pGL4.10 luc2 vector (Promega, USA). Transfections mediated by Lipofectamine™ 2000 for HEK293T cells or Lipofectamine™ LTX Reagent with PLUS™ Reagent (Invitrogen, California, USA) for tammar primary cells were carried out according to the manufacturer's protocol using the same molar constructs in triplicate. Luciferase enzyme was extracted at 24 hours for HEK293T cells or 48 hours for tammar cells post-transfection using luciferase assay kit from Promega. Luciferase activity was measured using single-tube luminometers with injectors based on standard method, normalized to background levels of luciferase activity derived from negative control cells. In each group, we set the minimal value as "1", and then calculated the relative values for others. The data shown represent mean values from triplicate reads (± S.E.M).
Chromosome Preparations and Fluorescence in Situ Hybridisation
Chromosome preparations were made from peripheral blood according to standard methods with minor modifications . Briefly, the cells were cultivated in DME supplemented with 10% FCS. The peripheral lymphocytes were stimulated with either phytohemagglutinin (Murex) or staphylococcal enterotoxin A (Sigma). After 70.5 h, the cultures were treated with Colcemid (0.05 mg/ml) for one hour. The cells were then harvested by centrifugation, resuspended in hypotonic solution (0.4% KCl) for 30 min at 37°C, and pre-fixed by adding and resuspending 1 ml of fixative (methanol:acetic acid; 3:1). Cells were then washed three times with fixative and kept at -20°C overnight. Chromosomes were spread on dry, acetone-cleaned slides by applying drops of cell suspension from a height of 15 cm to 20 cm. Slides were air-dried for 24 h, dehydrated, air-dried, and stored at -80°C.
Chromosome in situ suppression (CISS) hybridization was performed as previously described with minor modifications . The BAC genomic clone was screened with tammar WNT4 cDNA probe , labelled with dUTP-digoxygenin (DIG) by nick translation at 14°C for about one hour and co-precipitated with tammar wallaby Cot-1 DNA prior to hybridization. The probe was hybridized to tammar metaphase chromosome spreads at 37°C overnight. Hybridization was detected using mouse anti-DIG-FITC antibody (Serva). After CISS hybridization, the chromosome preparations were stained with DAPI (4, 6-diamidino-2-phenylindole) to visualize the chromosomes. Images were taken using a Zeiss microscope, and then merged and edited.
We thank Susan Osborn for the tammar primary cell lines and Giovanna D'Abaco (Department of surgery, the University of Melbourne) for HEK293T cells. We also thank Natasha Sankovic and Amber Alsop for advice on the fluorescence in situ hybridization (FISH). This work was supported by the Australian Research Council Centre for Kangaroo Genomics, a Federation Fellowship to MBR and a National Health and Medical Research Council RD Wright Fellowship to AJP.
- Takata H, Terada K, Oka H, Sunada Y, Moriguchi T, Nohno T: Involvement of Wnt4 signaling during myogenic proliferation and differentiation of skeletal muscle. Dev Dyn. 2007, 236 (10): 2800-2807. 10.1002/dvdy.21327.View ArticlePubMedGoogle Scholar
- Inaki M, Yoshikawa S, Thomas JB, Aburatani H, Nose A: Wnt4 Is a Local Repulsive Cue that Determines Synaptic Target Specificity. Curr Biol. 2007, 17 (18): 1574-1579. 10.1016/j.cub.2007.08.013.View ArticlePubMedGoogle Scholar
- Itaranta P, Chi L, Seppanen T, Niku M, Tuukkanen J, Peltoketo H, Vainio S: Wnt-4 signaling is involved in the control of smooth muscle cell fate via Bmp-4 in the medullary stroma of the developing kidney. Dev Biol. 2006, 293 (2): 473-483. 10.1016/j.ydbio.2006.02.019.View ArticlePubMedGoogle Scholar
- Kobayashi T, Tanaka H, Kuwana H, Inoshita S, Teraoka H, Sasaki S, Terada Y: Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun. 2005, 336 (2): 585-595. 10.1016/j.bbrc.2005.08.136.View ArticlePubMedGoogle Scholar
- Lyons JP, Mueller UW, Ji H, Everett C, Fang X, Hsieh JC, Barth AM, McCrea PD: Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp Cell Res. 2004, 298 (2): 369-387. 10.1016/j.yexcr.2004.04.036.View ArticlePubMedGoogle Scholar
- Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M: Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci. 2003, 94 (7): 593-597. 10.1111/j.1349-7006.2003.tb01488.x.View ArticlePubMedGoogle Scholar
- Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E: Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc Natl Acad Sci USA. 2003, 100 (19): 10866-10871. 10.1073/pnas.1834480100.PubMed CentralView ArticlePubMedGoogle Scholar
- Jeays-Ward K, Hoyle C, Brennan J, Dandonneau M, Alldus G, Capel B, Swain A: Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development. 2003, 130 (16): 3663-3670. 10.1242/dev.00591.View ArticlePubMedGoogle Scholar
- Li Q, Kannan A, Wang W, Demayo FJ, Taylor RN, Bagchi MK, Bagchi IC: Bone Morphogenetic Protein 2 Functions via a Conserved Signaling Pathway Involving Wnt4 to Regulate Uterine Decidualization in the Mouse and the Human. J Biol Chem. 2007, 282 (43): 31725-31732. 10.1074/jbc.M704723200.View ArticlePubMedGoogle Scholar
- Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature. 1994, 372 (6507): 679-683. 10.1038/372679a0.View ArticlePubMedGoogle Scholar
- Lee HH, Behringer RR: Conditional expression of Wnt4 during chondrogenesis leads to dwarfism in mice. PLoS ONE. 2007, 2 (5): e450-10.1371/journal.pone.0000450.PubMed CentralView ArticlePubMedGoogle Scholar
- Bernard P, Harley VR: Wnt4 action in gonadal development and sex determination. Int J Biochem Cell Biol. 2007, 39 (1): 31-43. 10.1016/j.biocel.2006.06.007.View ArticlePubMedGoogle Scholar
- Yu H, Pask AJ, Shaw G, Renfree MB: Differential expression of WNT4 in testicular and ovarian development in a marsupial. BMC Dev Biol. 2006, 6: 44-10.1186/1471-213X-6-44.PubMed CentralView ArticlePubMedGoogle Scholar
- Colwell AS, Krummel TM, Longaker MT, Lorenz HP: Wnt-4 expression is increased in fibroblasts after TGF-beta1 stimulation and during fetal and postnatal wound repair. Plast Reconstr Surg. 2006, 117 (7): 2297-2301. 10.1097/01.prs.0000218708.16909.31.View ArticlePubMedGoogle Scholar
- Oshima Y, Hayashi T, Tokunaga S, Nakamura M: Wnt4 expression in the differentiating gonad of the frog Rana rugosa. Zoolog Sci. 2005, 22 (6): 689-693. 10.2108/zsj.22.689.View ArticlePubMedGoogle Scholar
- Maurus D, Heligon C, Burger-Schwarzler A, Brandli AW, Kuhl M: Noncanonical Wnt-4 signaling and EAF2 are required for eye development in Xenopus laevis. Embo J. 2005, 24 (6): 1181-1191. 10.1038/sj.emboj.7600603.PubMed CentralView ArticlePubMedGoogle Scholar
- Heikkila M, Prunskaite R, Naillat F, Itaranta P, Vuoristo J, Leppaluoto J, Peltoketo H, Vainio S: The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology. 2005, 146 (9): 4016-4023. 10.1210/en.2005-0463.View ArticlePubMedGoogle Scholar
- Jeays-Ward K, Dandonneau M, Swain A: Wnt4 is required for proper male as well as female sexual development. Dev Biol. 2004, 276 (2): 431-440. 10.1016/j.ydbio.2004.08.049.View ArticlePubMedGoogle Scholar
- Surendran K, McCaul SP, Simon TC: A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol. 2002, 282 (3): F431-441.View ArticlePubMedGoogle Scholar
- Saulnier DM, Ghanbari H, Brandli AW: Essential function of Wnt-4 for tubulogenesis in the Xenopus pronephric kidney. Dev Biol. 2002, 248 (1): 13-28. 10.1006/dbio.2002.0712.View ArticlePubMedGoogle Scholar
- Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O, Vainio S: Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology. 2002, 143 (11): 4358-4365. 10.1210/en.2002-220275.View ArticlePubMedGoogle Scholar
- Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP: Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999, 397 (6718): 405-409. 10.1038/17068.View ArticlePubMedGoogle Scholar
- Kispert A, Vainio S, McMahon AP: Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development. 1998, 125 (21): 4225-4234.PubMedGoogle Scholar
- Ungar AR, Kelly GM, Moon RT: Wnt4 affects morphogenesis when misexpressed in the zebrafish embryo. Mech Dev. 1995, 52 (2-3): 153-164. 10.1016/0925-4773(95)00386-F.View ArticlePubMedGoogle Scholar
- Cai Y, Lechner MS, Nihalani D, Prindle MJ, Holzman LB, Dressler GR: Phosphorylation of Pax2 by the c-Jun N-terminal kinase and enhanced Pax2-dependent transcription activation. J Biol Chem. 2002, 277 (2): 1217-1222. 10.1074/jbc.M109663200.View ArticlePubMedGoogle Scholar
- Torban E, Dziarmaga A, Iglesias D, Chu LL, Vassilieva T, Little M, Eccles M, Discenza M, Pelletier J, Goodyer P: PAX2 activates WNT4 expression during mammalian kidney development. J Biol Chem. 2006, 281 (18): 12705-12712. 10.1074/jbc.M513181200.View ArticlePubMedGoogle Scholar
- Renfree MB: Society for Reproductive Biology Founders' Lecture 2006 - life in the pouch: womb with a view. Reprod Fertil Dev. 2006, 18 (7): 721-734. 10.1071/RD06072.View ArticlePubMedGoogle Scholar
- Renfree MB, Pask AJ, Shaw G: Sex down under: the differentiation of sexual dimorphisms during marsupial development. Reprod Fertil Dev. 2001, 13 (7-8): 679-690. 10.1071/RD01096.View ArticlePubMedGoogle Scholar
- Renfree MB, Harry JL, Shaw G: The marsupial male: a role model for sexual development. Philos Trans R Soc Lond B Biol Sci. 1995, 350 (1333): 243-251. 10.1098/rstb.1995.0158.View ArticlePubMedGoogle Scholar
- Sim EU, Smith A, Szilagi E, Rae F, Ioannou P, Lindsay MH, Little MH: Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene. 2002, 21 (19): 2948-2960. 10.1038/sj.onc.1205373.View ArticlePubMedGoogle Scholar
- Devgan V, Mammucari C, Millar SE, Brisken C, Dotto GP: p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 2005, 19 (12): 1485-1495. 10.1101/gad.341405.PubMed CentralView ArticlePubMedGoogle Scholar
- Delavaine L, La Thangue NB: Control of E2F activity by p21Waf1/Cip1. Oncogene. 1999, 18 (39): 5381-5392. 10.1038/sj.onc.1202923.View ArticlePubMedGoogle Scholar
- Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, Chaboissier MC, Poulat F, Behringer RR, Lovell-Badge R, Capel B: Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol. 2006, 4 (6): e187-10.1371/journal.pbio.0040187.PubMed CentralView ArticlePubMedGoogle Scholar
- Osada M, Park HL, Nagakawa Y, Begum S, Yamashita K, Wu G, Kim MS, Trink B, Sidransky D: A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochem Biophys Res Commun. 2006, 339 (4): 1120-1128. 10.1016/j.bbrc.2005.11.118.View ArticlePubMedGoogle Scholar
- Wakefield MJ, Graves JA: The kangaroo genome. Leaps and bounds in comparative genomics. EMBO Rep. 2003, 4 (2): 143-147. 10.1038/sj.embor.embor739.PubMed CentralView ArticlePubMedGoogle Scholar
- Bininda-Emonds OR, Cardillo M, Jones KE, MacPhee RD, Beck RM, Grenyer R, Price SA, Vos RA, Gittleman JL, Purvis A: The delayed rise of present-day mammals. Nature. 2007, 446 (7135): 507-512. 10.1038/nature05634.View ArticlePubMedGoogle Scholar
- Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao PN, Elejalde BR, Vilain E: Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet. 2001, 68 (5): 1102-1109. 10.1086/320125.PubMed CentralView ArticlePubMedGoogle Scholar
- Peltoketo H, Allinen M, Vuosku J, Kujala S, Lundan T, Salminen A, Winqvist R, Vainio S: Characterization and expression of the human WNT4; lack of associated germline mutations in high--to moderate--risk breast and ovarian cancer. Cancer Lett. 2004, 213 (1): 83-90. 10.1016/j.canlet.2004.02.024.View ArticlePubMedGoogle Scholar
- Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA: Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes & development. 2000, 14 (6): 650-654.Google Scholar
- Marin M, Karis A, Visser P, Grosveld F, Philipsen S: Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 1997, 89 (4): 619-628. 10.1016/S0092-8674(00)80243-3.View ArticlePubMedGoogle Scholar
- Zhao C, Meng A: Sp1-like transcription factors are regulators of embryonic development in vertebrates. Dev Growth Differ. 2005, 47 (4): 201-211. 10.1111/j.1440-169X.2005.00797.x.View ArticlePubMedGoogle Scholar
- Remington MC, Tarle SA, Simon B, Merchant JL: ZBP-89, a Kruppel-type zinc finger protein, inhibits cell proliferation. Biochem Biophys Res Commun. 1997, 237 (2): 230-234. 10.1006/bbrc.1997.7119.View ArticlePubMedGoogle Scholar
- Malo MS, Mozumder M, Zhang XB, Biswas S, Chen A, Bai LC, Merchant JL, Hodin RA: Intestinal alkaline phosphatase gene expression is activated by ZBP-89. Am J Physiol Gastrointest Liver Physiol. 2006, 290 (4): G737-746. 10.1152/ajpgi.00394.2005.View ArticlePubMedGoogle Scholar
- Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell. 2002, 109 (Suppl): S81-96. 10.1016/S0092-8674(02)00703-1.View ArticlePubMedGoogle Scholar
- Brophy PD, Ostrom L, Lang KM, Dressler GR: Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development (Cambridge, England). 2001, 128 (23): 4747-4756.Google Scholar
- Wheat W, Fitzsimmons D, Lennox H, Krautkramer SR, Gentile LN, McIntosh LP, Hagman J: The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes. Mol Cell Biol. 1999, 19 (3): 2231-2241.PubMed CentralView ArticlePubMedGoogle Scholar
- Berkes CA, Tapscott SJ: MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol. 2005, 16 (4-5): 585-595. 10.1016/j.semcdb.2005.07.006.View ArticlePubMedGoogle Scholar
- Carey M, Smale ST: Transcriptional Regulation in Eukaryotes Concepts, Strategies, and Techniques. 2000, New York: Cold Spring Harbor Laboratory PressGoogle Scholar
- Hoffman AR, Hu JF: Directing DNA methylation to inhibit gene expression. Cell Mol Neurobiol. 2006, 26 (4-6): 425-438. 10.1007/s10571-006-9057-5.View ArticlePubMedGoogle Scholar
- Kapoor A, Agius F, Zhu JK: Preventing transcriptional gene silencing by active DNA demethylation. FEBS Lett. 2005, 579 (26): 5889-5898. 10.1016/j.febslet.2005.08.039.View ArticlePubMedGoogle Scholar
- Schempp W, Meer B: Cytologic evidence for three human X-chromosomal segments escaping inactivation. Hum Genet. 1983, 63 (2): 171-174. 10.1007/BF00291539.View ArticlePubMedGoogle Scholar
- Wilcox SA, Toder R, Foster JW: Rapid isolation of recombinant lambda phage DNA for use in fluorescence in situ hybridization. Chromosome Res. 1996, 4 (5): 397-398. 10.1007/BF02257276.View ArticlePubMedGoogle Scholar
- Grafodatskaya D, Rens W, Wallis MC, Trifonov V, O'Brien PC, Clarke O, Graves JA, Ferguson-Smith MA: Search for the sex-determining switch in monotremes: mapping WT1, SF1, LHX1, LHX2, FGF9, WNT4, RSPO1 and GATA4 in platypus. Chromosome Res. 2007, 15 (6): 777-785. 10.1007/s10577-007-1161-y.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.